De-risk life sciences investing before you write the check.
The Clarity Index runs the diligence groundwork — 17+ data sources, continuous monitoring, evidence-weighted scoring — so your team spends its time on judgment, not research.
Three assessments a month, free — no card required. See pricing
Your junior analyst, always on.
Every company you're evaluating gets a Clarity Score built from clinical trial data, regulatory filings, patent activity, and published evidence — continuously updated as new information appears. You still make the call. We just make sure you're making it with the full picture.
Evaluate
Every company is scored against a rigorous, literature-grounded framework covering scientific validity and commercial viability — not marketing claims.
Compare
Put up to four companies side by side across every scoring dimension and see exactly where each one sits on the Clarity Map.
Track
Add companies to a watchlist and get monitoring reports as new evidence, trials, or regulatory developments emerge.
Two scores, one clear picture
Every company is plotted on a 2x2 quadrant framework so you can instantly see the trade-off between scientific rigor and commercial readiness.
Scientific Validity Score
Mechanism novelty, mechanism validation, clinical evidence quality, translation risk, and regulatory clarity — scored 0-10 from the literature alone.
Commercial Viability Score
Market precedent, competitive landscape, time to market, IP defensibility, and funding / team traction — scored 0-10 from public commercial data.
Inside the database
Illustrative examples — the full database includes vetted companies across longevity, regenerative medicine, and biotech.
NeuroRestore Therapeutics
Senolytix Bio
Helix Diagnostics
Every score shows its work
Each assessment includes an Evidence Audit — full transparency into how many sources were searched, how many papers were found, and how much of the evidence base was actually reviewed in full text versus abstract only.
Deal Flow Intelligence
Emerging companies surfaced before they appear on PitchBook or Crunchbase — university spinouts, SBIR winners, patent clusters, and high-momentum research, pre-assessed daily by our Discovery Agent.
Example: Meridian Senolytics Lab
A representative sample of what a real Deal Flow signal looks like: a novel small-molecule senolytic identified from an NIH-funded academic lab, with early in vivo validation and a PI actively discussing licensing.
A representative example — real signals include specific evidence, scores, and a recommended next action.
Illustrative placeholder — unlock to see real, sourced risk assessments.
Example: Meridian Senolytics Lab
A representative sample of what a real Deal Flow signal looks like: a novel small-molecule senolytic identified from an NIH-funded academic lab, with early in vivo validation and a PI actively discussing licensing.
A representative example — real signals include specific evidence, scores, and a recommended next action.
Illustrative placeholder — unlock to see real, sourced risk assessments.
Example: Meridian Senolytics Lab
A representative sample of what a real Deal Flow signal looks like: a novel small-molecule senolytic identified from an NIH-funded academic lab, with early in vivo validation and a PI actively discussing licensing.
A representative example — real signals include specific evidence, scores, and a recommended next action.
Illustrative placeholder — unlock to see real, sourced risk assessments.
Available on Individual and Institutional plans
Deal Flow Intelligence surfaces emerging companies before they appear on PitchBook or Crunchbase — updated daily.
Get Early AccessWho it's built for
Family Offices
Vet deal flow before capital commitment, with scientific due diligence built in.
Private Investors
Understand what the science actually supports before you understand what the pitch says.
Investment Teams
Standardize how your team evaluates scientific risk across a growing pipeline.
Global coverage
Including deep visibility into Gulf & MENA life sciences activity.
Stay current
Weekly intelligence briefings on the sectors you track.
Built for teams
Shared watchlists and deal flow across your firm.
Straightforward pricing
Start free with three assessments a month. Upgrade when the framework is carrying real weight in your process — cancel any time from your account.
Free
$0
Evaluate the framework on your own deal flow.
- 3 assessments per month
- Full company database and Clarity Scores
- Watchlist and portfolio tracking
- Weekly intelligence briefings
Individual
Most popular$49/mo
For investors running their own diligence.
- Unlimited assessments
- Investment thesis and red flags on every company
- Side-by-side comparison across every dimension
- Signals and full Deal Flow intelligence
- Continuous monitoring reports
Institutional
$500/mo
For funds and family offices with a diligence process.
- Everything in Individual
- Due diligence checklists
- Comparable exits analysis
- Bear case for every company
- The One Question
Need something bespoke?
Multi-seat access, custom coverage, or diligence support for a larger fund — tell us what you need and we'll come back to you within 48 hours.